VIRTUAL TOUR Welcome to one of our state-of-the-art facilities

The new 31,000-sq. ft building will bring additional commercial spray drying capacity for customers who favour US-based manufacturing

Hovione announced today the appointment of Dr. Jean-Luc Herbeaux as Chief Operating Officer (COO), effective May 1st, 2020.

Hovione announced the signing of a partnership agreement with Ligand to significantly ramp up the production output of Captisol®

Ventofor Combi Fix delivered by the PowdAir Plus dry powder inhaler.

The 8Shot DPI is capable of delivering high doses of drug to the lungs.

TwinMax enabes delivery of doses up to 100 mg formulated as drug alone or engineered particles.

The device's blister is designed to provide flexibility to pharmaceutical partners delivering a wide range of inhaled drugs for both acute and chronic respiratory treatments.

One-Site-Stop

This sun, this sea is what inspired the Portuguese to be the first to sail around the world five centuries ago. Today, discovery still requires courage, a willingness to take risk, and the best technologies. At Hovione this is what we do. We give clients what they cannot find elsewhere, we do well what is difficult. 
We work to help develop new and better medicines. Chemistry, processing and mathematical models are subjects we master, but it all begins and ends with the people. The almost 2000 committed, creative, rigorous, highly qualified team members coming from all parts of the world in which we operate. To contribute to their talent development is one of our major challenges and achievements.

Hovione #WeFightBack

Introduction to Hovione’s new formulation screening platform by Spray Drying Learn about the advantages of a platform that integrates in silico computational models, formulation, analytical development Get to know more about Hovione’s extensive expertise in Spray Drying This session was originally broadcast live as part of CPHI North America 2021

WATCH WEBINAR

The Coming of Age of Amorphous Solid Dispersions

In recent years, numerous drugs formulated as amorphous solid dispersions (ASDs) have been successfully commercialized, confirming the effectiveness of these technologies. Get to learn more with this scientific article. During the 10 days’ event meet with Hovione’s experts safely online and find how our experienced multi-disciplinary teams and their innovative work can help your project succeed.

READ ARTICLE The Coming of Age of Amorphous Solid Dispersions In recent years, numerous drugs formulated as amorphous solid dispersions (ASDs) have been successfully commercialized, confirming the effectiveness of these technologies. Get to learn more with this scientific article. During the 10 days’ event meet with Hovione’s experts safely online and find how our experienced multi-disciplinary teams and their innovative work can help your project succeed.